ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease (VAAST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01604213
Recruitment Status : Completed
First Posted : May 23, 2012
Last Update Posted : April 19, 2016
Sponsor:
Information provided by (Responsible Party):
Dr. Robert Klempfner Heart Rehabilitation Institute, Sheba Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2016
  Actual Study Completion Date : April 2016
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):